06 March 2024>: Clinical Research
Molecular Determinants of Drug Resistance and Mutation Patterns in Influenza Viruses Circulating in Poland Across Multiple Epidemic Seasons: Implications for Vaccination Strategies
Ewelina Hallmann 1ABDEFG* , Aleksander Masny 1AD , Anna Poznańska 2CD , Francisco Pozo 34A , Inmaculada Casas 34A , Lidia Bernadeta Brydak 1ADDOI: 10.12659/MSM.942125
Med Sci Monit 2024; 30:e942125
Figure 3 Structure of the neuraminidase virus A/SingaporeINFIMH-16-0019/2016(A/H3N2/) with the D356H mutation detected in clinical sample number 25, as an example of a ligand-binding mutation. Mutation site 356 is shown in red on the A chain (yellow backbone), which is 5 Ångström (A) from the ligand-binding site (created using the FluSurver mutations app – https://gisaid.org/database-features/flusurver-mutations-app/).